CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
AIDANET +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06633965
NCT06633965N/ACompleted
CompareCT.gov

Safety and Feasibility Testing of a Smaller Network Version of AIDANET (MiniNET)

Marc Breton·interventional·Posted Oct 9, 2024·Updated Aug 14, 2025

In Brief

A clinical study evaluating AIDANET for Type 1 Diabetes. Completed, enrolled 8 participants across 1 site.

Detailed Summary

A randomized 1:1 crossover trial that intends to demonstrate feasibility and safety of the Automated Insulin Delivery as Adaptive NETwork (AIDANET) system run in a new smaller network version, used in full closed loop (FCL) by adults who have been diagnosed with type 1 diabetes (T1D).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsTandem Diabetes Care, Inc., DexCom, Inc.

Timeline

N/ACompletedFinished
20252026
First PostedOct 9, 2024
Enrollment StartNov 20, 2024
Primary CompletionDec 16, 2024
Study CompletionDec 18, 2024
TodayJul 2, 2026
Enrollment to primary: 26 daysPosted 1.7 years ago

Interventions

AIDANETdevice

AIDANET is a fully automated, utilizing a Bolus Priming System (BPS) that recognizes meal ingestion and delivers a quick priming dose of insulin prior to extreme blood sugar excursions.

AIDANETdevice

AIDANET is a fully automated, utilizing a Bolus Priming System (BPS) that recognizes meal ingestion and delivers a quick priming dose of insulin prior to extreme blood sugar excursions.